Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001123292-24-000350
Filing Date
2024-11-14
Accepted
2024-11-14 16:07:02
Documents
1

Document Format Files

Seq Description Document Type Size
1 portage13d.htm SC 13D/A 128533
  Complete submission text file 0001123292-24-000350.txt   130083
Mailing Address CLARENCE THOMAS BUILDING P.O. BOX 4649, ROAD TOWN TORTOLA D8 VG1110
Business Address CLARENCE THOMAS BUILDING P.O. BOX 4649, ROAD TOWN TORTOLA D8 VG1110 416-737-7600
PORTAGE BIOTECH INC. (Subject) CIK: 0001095435 (see all company filings)

EIN.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 0331
Type: SC 13D/A | Act: 34 | File No.: 005-81765 | Film No.: 241462024
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 4 A CHESHAM STREET LONDON X0 SW1X8DT
Business Address
Bailey Gregory (Filed by) CIK: 0001329505 (see all company filings)

Type: SC 13D/A